Addressing catheter lock therapy: Does heparin reduce the bioactivity of dalbavancin when together in solution during freezing? Marta Díaz-Navarro; Rama Hafian; María Jesús Pérez-Granda; Emilia Cercenado; Patricia Muñoz; María Guembe;

Dalbavancin as sequential therapy in infective endocarditis: Real-life experience in elder and comorbid patients Eduardo Aparicio-Minguijón; Jorge Boán; Antonio Terrón; Carlos Heredia; Cristina Puente; Asunción Pérez-Jacoiste Asín; M. Ángeles Orellana; Laura Domínguez; José Manuel Caro; M. Jesús López-Gude; Eva María Aguilar-Blanco; Andrea Eixerés-Esteve; Francisco López-Medrano;

Dalbavancin as consolidation antibiotic treatment in infective endocarditis, cardiac implantable electronic devices infection and bacteremia: Clinical experience of 7 years Alejandro Salinas-Botrán; Carmen Olmos-Blanco; David Fernández de Velasco-Pérez; Alicia Guzmán-Carreras; Alejandro Morales-Rosas; Daniel Gómez-Ramírez;